The clinical impact of coronavirus infection in patients with hematologic malignancies and hematopoietic stem cell transplant recipients

CoV is frequently detected in HSCT and hematologic malignancy patients in whom suspicion for a respiratory viral infection exists, but is less likely to progress to lower respiratory tract disease than most other respiratory viruses.